Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer
about
Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Fulvestrant, Palbociclib and E ...... ified Metastatic Breast Cancer
@en
type
label
Fulvestrant, Palbociclib and E ...... ified Metastatic Breast Cancer
@en
prefLabel
Fulvestrant, Palbociclib and E ...... ified Metastatic Breast Cancer
@en
P1476
A Phase Ib Trial of Fulvestran ...... Metastatic Breast Cancer (MBC)
@en
P3098
NCT03238196
P580
2017-08-10T00:00:00Z
P582
2020-09-01T00:00:00Z